The European Innovation Council's Accelerator has awarded Aligned Bio €2.3 million in funding, with the possibility of a further €2.3 million in venture capital. This is to accelerate the company's efforts to detect biomarkers at the molecular level using the patented Aerotaxy nanowire production process.
This spring, the company is expected to close a new share issue of another SEK 50-60 million.